\-\ Texto\\:\\ \ \(0\)\
\-\ non\\ contributory\\ physical\\ exam\\.\ \(0\)\
\-\ no\\ labs\\.\ \(1\)\
\-\ 1\\)\\ drugs\\ \\(nitrates\\,\\ beta\\ agonists\\,\\ calcium\\ channel\\ blockers\\)\\ \\-\\ effective\\ in\\ 50\\%\\.\ \(0\)\
\-\ 2\\)\\ balloon\\ dilitation\\ \\-\\ effective\\ in\\ 70\\%\\.\ \(0\)\
\-\ 3\\)\\ myotomy\\.\ \(0\)\
\-\ conical\\ narrowing\\ of\\ distal\\ esophageal\\ segment\\.\ \(0\)\
\-\ marked\\ proximal\\ esophageal\\ dilitation\\.\ \(0\)\
\-\ dysmotility\\ \\-\\ no\\ coordinated\\ contractions\\ \\(aperistaltic\\)\\.\\ tertiary\\ contractile\\ activity\\.\\ \ \(0\)\
\-\ poor\\ esophageal\\ emptying\\.\ \(0\)\
\-\ achalasia\ \(51\)\
\-\ 1\\)\\ achalasia\ \(0\)\
\-\ 2\\)\\ esophageal\\ spasm\ \(0\)\
\-\ 3\\)\\ scleroderma\ \(0\)\
\-\ 4\\)\\ infection\\ \\-\\ chagas\\ disease\ \(0\)\
\-\ 5\\)\\ neoplasm\\ \\-\\ fundal\\ carcinoma\\,\\ lymphoma\ \(0\)\
\-\ 6\\)\\ metastasis\\ \ \(0\)\
\-\ 7\\)\\ reflux\\ esophagitis\ \(0\)\
\-\ 35\\ year\\ old\\ male\\ with\\ dysphagia\\ and\\ an\\ epigastric\\ burning\\ sensation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ esophageal\\:\\ 0\\.3885315512380144\ \(0\)\
\-\ dilitation\\:\\ 0\\.26802581633909134\ \(0\)\
\-\ achalasia\\:\\ 0\\.25566385777357525\ \(0\)\
\-\ effective\\:\\ 0\\.23223622940532762\ \(0\)\
\-\ aperistaltic\\:\\ 0\\.18179980320437342\ \(0\)\
\-\ contractile\\:\\ 0\\.18179980320437342\ \(0\)\
\-\ coordinated\\:\\ 0\\.16798629269085977\ \(0\)\
\-\ nitrates\\:\\ 0\\.1635393355675378\ \(0\)\
\-\ conical\\:\\ 0\\.1599059070371369\ \(0\)\
\-\ dysmotility\\:\\ 0\\.1599059070371369\ \(0\)\
\-\ agonists\\:\\ 0\\.1568338869868801\ \(0\)\
\-\ contractions\\:\\ 0\\.14609239652362324\ \(0\)\
\-\ chagas\\:\\ 0\\.14609239652362324\ \(0\)\
\-\ myotomy\\:\\ 0\\.14164543940030128\ \(0\)\
\-\ blockers\\:\\ 0\\.14035927166383255\ \(0\)\
\-\ tertiary\\:\\ 0\\.14035927166383255\ \(0\)\
\-\ fundal\\:\\ 0\\.14035927166383255\ \(0\)\
\-\ burning\\:\\ 0\\.13801201086990034\ \(0\)\
\-\ emptying\\:\\ 0\\.13693452235029027\ \(0\)\
\-\ esophagitis\\:\\ 0\\.13591231454051056\ \(0\)\
\-\ channel\\:\\ 0\\.13146535741718857\ \(0\)\
\-\ scleroderma\\:\\ 0\\.12717847089834755\ \(0\)\
\-\ balloon\\:\\ 0\\.11888494221699242\ \(0\)\
\-\ beta\\:\\ 0\\.11805446025587317\ \(0\)\
\-\ epigastric\\:\\ 0\\.11687022973969441\ \(0\)\
\-\ spasm\\:\\ 0\\.11504062618305375\ \(0\)\
\-\ drugs\\:\\ 0\\.1136890111525743\ \(0\)\
\-\ calcium\\:\\ 0\\.10267711378469492\ \(0\)\
\-\ dysphagia\\:\\ 0\\.10267711378469492\ \(0\)\
\-\ reflux\\:\\ 0\\.09845705114016091\ \(0\)\
\-\ sensation\\:\\ 0\\.09741963639861308\ \(0\)\
\-\ poor\\:\\ 0\\.09589125346165638\ \(0\)\
\-\ 70\\:\\ 0\\.09385854436547351\ \(0\)\
\-\ segment\\:\\ 0\\.09385854436547351\ \(0\)\
\-\ 35\\:\\ 0\\.09115219848517049\ \(0\)\
\-\ narrowing\\:\\ 0\\.08812541950568278\ \(0\)\
\-\ marked\\:\\ 0\\.08598048210552392\ \(0\)\
\-\ activity\\:\\ 0\\.08346223585122327\ \(0\)\
\-\ metastasis\\:\\ 0\\.08331937729598998\ \(0\)\
\-\ 50\\:\\ 0\\.07939157586351976\ \(0\)\
\-\ labs\\:\\ 0\\.07875886611549114\ \(0\)\
\-\ contributory\\:\\ 0\\.07771119756720161\ \(0\)\
\-\ neoplasm\\:\\ 0\\.07760405385150987\ \(0\)\
\-\ no\\:\\ 0\\.07393518384430982\ \(0\)\
\-\ proximal\\:\\ 0\\.07102110236412544\ \(0\)\
\-\ infection\\:\\ 0\\.06866957555645221\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06799851272312596\ \(0\)\
\-\ lymphoma\\:\\ 0\\.06770375279245747\ \(0\)\
\-\ distal\\:\\ 0\\.0660511720341259\ \(0\)\
\-\ physical\\:\\ 0\\.06164015483599122\ \(0\)\
\-\ exam\\:\\ 0\\.05722680022136647\ \(0\)\
\-\ in\\:\\ 0\\.05656001789834652\ \(0\)\
\-\ non\\:\\ 0\\.05393906717012419\ \(0\)\
\-\ male\\:\\ 0\\.050614913705122125\ \(0\)\
\-\ disease\\:\\ 0\\.047719018409507055\ \(0\)\
\-\ an\\:\\ 0\\.04347102615513741\ \(0\)\
\-\ year\\:\\ 0\\.03503407947091624\ \(0\)\
\-\ old\\:\\ 0\\.03364484363964768\ \(0\)\
\-\ and\\:\\ 0\\.02349067519104103\ \(0\)\
\-\ with\\:\\ 0\\.022260055205005846\ \(0\)\
\-\ of\\:\\ 0\\.02224676276955215\ \(0\)\
